膀胱炎性肌纤维母细胞瘤的临床特征分析(附2例报告)  

Clinical features of inflammatory myofibroblastic tumor of bladder:a report of 2 cases and literature review

作　　者：余勇军[1] 戴一菲[1] 魏卓 祝存海[1] YU Yong-jun;DAI Yi-fei;WEI Zhuo;ZHU Cun-hai(Department of Urology,Central Hospital of Xiaogan,Wuhan University of Science and Technology,Xiaogan 432000,China)

机构地区：[1]孝感市中心医院武汉科技大学附属孝感医院泌尿外科,432000

出　　处：《现代泌尿生殖肿瘤杂志》2018年第6期332-334,共3页Journal of Contemporary Urologic and Reproductive Oncology

摘　　要：目的探讨膀胱炎性肌纤维母细胞瘤的临床特征,提高对该疾病的认识和诊疗水平。方法分析2016年5月至2017年4月孝感市中心医院收治的2例膀胱炎性肌纤维母细胞瘤患者的临床资料并进行文献复习。结果 2例患者通过经尿道等离子膀胱肿瘤切除术后治愈。结论膀胱炎性肌纤维母细胞瘤为一种低度恶性的少见肿瘤性病变,术前影像学诊断困难,依靠病理可确诊,免疫组化对疾病的诊断和预后有一定的指导意义。一般采用保留膀胱的外科手术治疗,术后应注意随访。Objective To investigate the clinical features of inflammatory myofibroblastic tumor of bladder and to improve the understanding of the disease and its diagnosis and treatment.Methods The clinical data of 2 patients with inflammatory myofibroblastic tumor treated in Xiaogan Central Hospital from May 2016 to April 2017 were analyzed and the literature was reviewed. Results Both 2 patients were cured by transurethral resection of bladder tumor. Conclusions Inflammatory myofibroblastic tumor is a rare tumor with low malignancy.It is difficult to diagnose by imaging before operation and can be confirmed by pathology.Immunohistochemistry can be used to guide the diagnosis and prognosis of inflammatory myofibroblastic tumor.General bladder-preserving surgery can be used,and postoperative follow-up should be paid attention to.

关 键 词：膀胱炎性肌纤维母细胞瘤 临床特征 诊断 治疗 

分 类 号：R737.14[医药卫生—肿瘤]